Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Affibody and Creative Antibiotics to collaborate on targeted antibiotics

Feb. 3, 2012

Eusa Pharma acquires Asparec rights

Feb. 2, 2012

Impax Pharmaceuticals gains U.S. rights to migraine therapy

Feb. 2, 2012

Shire and Sangamo BioSciences enter agreement for hemophilia therapeutics

Feb. 2, 2012

Astellas and UCB sign Japanese development and commercialization agreement for Cimzia

Feb. 1, 2012

Spectrum Pharmaceuticals in-licenses long-acting granulocyte colony-stimulating factor

Feb. 1, 2012

Takeda returns Posidur rights to Durect

Jan. 31, 2012

Orexo ends collaboration with Janssen

Jan. 31, 2012

Servier and Monash University establish GPCR collaboration

Jan. 31, 2012

Navidea Biopharmaceuticals enters into agreement for Parkinson's disease imaging agent

Jan. 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...